The
study of regulatory T cells has undergone a renaissance, driven in part
by the description of the CD4+CD25+ subset. Natural killer T (NKT)
cells constitute a second subpopulation that may have important
regulatory functions. NKT cells are typically identified as lymphocytes
that co-express NK1.1 and a T-cell receptor (TCR), but in mice the
majority of these cells have additional properties, including an
invariant CDR3a formed by rearrangement of Va14 to Ja18 (formerly Ja281)
that associates preferentially with diverse rearrangements of either
Vb8, Vb7 or Vb2, and reactivity to CD1d. Currently, the natural
ligand(s) presented by CD1d for Va14i T cell stimulation are unknown.
However, the Va14i T cell response to CD1d is greatly augmented by the
glycosphingolipid a-galactosyl ceramide (a-GalCer), isolated from the
marine sponge Agelas Mauritanius.
The Va14i NKT cells exhibit
unique functional properties, most notably the production of large
amounts of IL-4 and other cytokines within 90 minutes of TCR stimulation
in vivo. Because of their potent ability to secrete cytokines rapidly,
Va14i NKT cells are believed to have an immune regulatory role. The
results from the study of several animal models of autoimmune diseases,
as well as studies of human patients with type I diabetes and other
autoimmune diseases support this hypothesis. Va14i NKT cells might also
be involved in some circumstances in the prevention of tumor metastases
and the response to some infectious agents.
Ongoing efforts in the laboratory address 4 major questions:
First,
we reported recently that the development of NKT cells in the thymus
branch off from the conventional T cells at the double-positive stage
where random rearrangements of the TCRs take place. Studies are underway
to understand the specific signals required by uncommitted
double-positive precursors to decide to become a NKT cells.
While T cells develop in the
thymus, they undergo two processes of selection. The first one, known
as positive selection, ensure that mature lymphocytes exported to the
peripheral organs will express TCR capable of interacting properly with
the major histocompatibility molecules that present the antigenic
peptides. The second one, known as negative selection, makes sure that
immature T cells expressing TCR that react strongly with ubiquitous
self-antigens are eliminated.
Mature Va14i NKT cells
demonstrate some degrees of auto-reactivity for the CD1d molecules in
absence of added antigens. Our studies address the question of whether
or not Va14i NKT cells also undergo negative selection during their
development in the thymus. The frequency of Va14i T cells is reduced in a
variety of autoimmune diseases. Because of their apparent importance
for immune regulation, it is critical to define the factors governing
the maintenance of the Va14i T cell population. We have shown that the
homeostasis of Va14i NKT cells was not dependent on CD1d expression, and
was not affected by the presence of host NKT cells. Additionally, we
found that IL-15 was important in expansion and/or survival of Va14i NKT
cells, with IL-7 playing a lesser role. Further experiments are
designed to determine what are the other factors involved in the control
of NKT cells homeostasis.
Finally, our recent studies
showed that Va14i NKT cells are poised to produce both IL-4 and IFNg and
that this cytokine output cannot be altered by methods that polarize
conventional CD4+ T cells. Our lab is committed to understanding the
molecular mechanisms involved in the cytokine secretion by Va14i NKT
cells.